Mann mit Wirtschaftszeitung (Symbolbild).
Quelle: - pixabay.com:
Google
PR Newswire  | 

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
QuidelOrtho Corp 27,70 $ QuidelOrtho Corp Chart -0,43%
Zugehörige Wertpapiere:

SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, is sharing timely public health insights from Dr. Jonathan Temte, Professor of Family Medicine and Community Health at the University of Wisconsin-Madison.

In this 50th episode of QuidelOrtho Science Bytes, Dr. Temte outlines the seasonal challenges posed by influenza, RSV, COVID-19 and vaccine-preventable diseases such as measles and whooping cough. He emphasizes that early detection through rapid diagnostic testing, combined with data-driven surveillance and practical prevention measures, can help keep students healthy and in school.

Key points from Dr. Temte's discussion include:

  • Early detection supports better outcomes: Rapid diagnostics enable targeted treatment and help reduce unnecessary antibiotic use
  • Absenteeism data can signal outbreaks: Illness-related absences often predict community spread before it peaks
  • Prevention protects communities: Preventive practices reduce transmission in schools and at home

This episode reflects QuidelOrtho's commitment to equipping healthcare providers and the public with timely, actionable information. By highlighting expert insights and practical solutions, QuidelOrtho aims to reduce illness spread and safeguard community health.

The QuidelOrtho Science Bytes podcast is available on major streaming platforms and at: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.

About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day.

By offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@QuidelOrtho.com

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

Media@QuidelOrtho.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/science-bytes-podcast-explores-how-diagnostics-can-help-protect-students-and-communities-302535145.html

SOURCE QuidelOrtho Corporation


Für dich aus unserer Redaktion zusammengestellt

Dein Kommentar zum Artikel im Forum

Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend